Guillermo Herrera, MD, University of South Alabama College of Medicine, Mobile, AL, and Elba Turbat-Herrera, MD, University of South Alabama College of Medicine and the Mitchell Cancer Institute, Mobile, AL, discuss the role of lysosomes in amyloidogenesis by mesangial cells in the kidneys of patients with light chain (AL) amyloidosis, highlighting the possibility of developing drugs targeting this process to prevent renal damage. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.